Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase IIIb randomized, double‐blind, parallel‐group, GUIDE study: An analysis with considerations for future studies

Journal of the European Academy of Dermatology and VenereologyEarly View LETTER TO THE EDITOR Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study: An analysis with considerations for future studies This article relates to: Reply to Kiran Javaid and Cassidy Andruszka: Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study: An analysis with considerations for future studies K. Schäkel, Journal of the European Academy of Dermatology and Venereology First Published online: November 11, 2023 Kiran Javaid, Corresponding Author Kiran Javaid [email protected] orcid.org/0009-0002-0094-1073 Department of Medicine, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, USA Correspondence Kiran Javaid, Department of Medicine, Rowan School of Osteopathic Medicine, 1 Medical Center Dr, Stratford, NJ 08084, USA. Email: [email protected]Search for more papers by this authorCassidy Andruszka, Cassidy Andruszka [email protected] orcid.org/0009-0003-7730-0423 Department of Medicine, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, USASearch for more papers by this author Kiran Javaid, Corresponding Author Kiran Javaid [email protected] orcid.org/0009-0002-0094-1073 Department of Medicine, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, USA Correspondence Kiran Javaid, Department of Medicine, Rowan School of Osteopathic Medicine, 1 Medical Center Dr, Stratford, NJ 08084, USA. Email: [email protected]Search for more papers by this authorCassidy Andruszka, Cassidy Andruszka [email protected] orcid.org/0009-0003-7730-0423 Department of Medicine, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, USASearch for more papers by this author First published: 31 October 2023 https://doi.org/10.1111/jdv.19599Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Open Research DATA AVAILABILITY STATEMENT Data sharing is not applicable to this article as no new data were created or analyzed in this study. REFERENCES 1Schäkel K, Reich K, Asadullah K, Pinter A, Jullien D, Weisenseel P, et al. Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study. J Eur Acad Dermatol Venereol. 2023; 37(10): 2016–2027. https://doi.org/10.1111/jdv.19236 10.1111/jdv.19236 CASPubMedWeb of Science®Google Scholar 2Kouris A, Platsidaki E, Kouskoukis C, Christodoulou C. Psychological parameters of psoriasis. Psychiatrike. 2017; 28(1): 54–59. https://doi.org/10.22365/jpsych.2017.281.54 10.22365/jpsych.2017.281.54 CASGoogle Scholar 3Karamata VV, Gandhi AM, Patel PP, Sutaria A, Desai MK. A study of the use of drugs in patients suffering from psoriasis and their impact on quality of life. Indian J Pharm. 2017; 49(1): 84–88. CASGoogle Scholar 4Wei J, Zhu J, Xu H, Zhou D, Elder JT, Tsoi LC, et al. Alcohol consumption and smoking in relation to psoriasis: a Mendelian randomization study. Br J Dermatol. 2022; 187(5): 684–691. https://doi.org/10.1111/bjd.21718 10.1111/bjd.21718 PubMedWeb of Science®Google Scholar Citing Literature Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation